3-(1,3-benzothiazol-2-yl)-7-[ethyl(methyl)amino]chromen-2-one;3-[[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl]-methylamino]propane-1-sulfonic acid;tris(carbon dioxide);7-[ethyl(methyl)amino]-3-(1-phenylbenzimidazol-2-yl)chromen-2-one
C67H55N7O16S2 — CID 158921698
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(1,3-benzothiazol-2-yl)-7-[ethyl(methyl)amino]chromen-2-one;3-[[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl]-methylamino]propane-1-sulfonic acid;tris(carbon dioxide);7-[ethyl(methyl)amino]-3-(1-phenylbenzimidazol-2-yl)chromen-2-one
3-(1,3-benzothiazol-2-yl)-7-[ethyl(methyl)amino]chromen-2-one;3-[[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl]-methylamino]propane-1-sulfonic acid;tris(carbon dioxide);7-[ethyl(methyl)amino]-3-(1-phenylbenzimidazol-2-yl)chromen-2-one (PubChem CID 158921698) has the molecular formula C67H55N7O16S2 and a molecular weight of 1278.34 g/mol. Its IUPAC name is 3-(1,3-benzothiazol-2-yl)-7-[ethyl(methyl)amino]chromen-2-one;3-[[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl]-methylamino]propane-1-sulfonic acid;tris(carbon dioxide);7-[ethyl(methyl)amino]-3-(1-phenylbenzimidazol-2-yl)chromen-2-one.
Molecular Properties
| Compound Name | 3-(1,3-benzothiazol-2-yl)-7-[ethyl(methyl)amino]chromen-2-one;3-[[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl]-methylamino]propane-1-sulfonic acid;tris(carbon dioxide);7-[ethyl(methyl)amino]-3-(1-phenylbenzimidazol-2-yl)chromen-2-one |
|---|---|
| PubChem CID | 158921698 |
| Molecular Formula | C67H55N7O16S2 |
| Molecular Weight | 1278.34 g/mol |
| Exact Mass | 1277.31 |
| IUPAC Name | 3-(1,3-benzothiazol-2-yl)-7-[ethyl(methyl)amino]chromen-2-one;3-[[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl]-methylamino]propane-1-sulfonic acid;tris(carbon dioxide);7-[ethyl(methyl)amino]-3-(1-phenylbenzimidazol-2-yl)chromen-2-one |
| SMILES | CCN(C)c1ccc2cc(-c3nc4ccccc4n3-c3ccccc3)c(=O)oc2c1.CCN(C)c1ccc2cc(-c3nc4ccccc4s3)c(=O)oc2c1.CN(CCCS(=O)(=O)O)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1.O=C=O.O=C=O.O=C=O |
| InChI | InChI=1S/C25H21N3O2.C20H18N2O6S.C19H16N2O2S.3CO2/c1-3-27(2)19-14-13-17-15-20(25(29)30-23(17)16-19)24-26-21-11-7-8-12-22(21)28(24)18-9-5-4-6-10-18;1-22(9-4-10-29(24,25)26)14-8-7-13-11-15(20(23)28-18(13)12-14)19-21-16-5-2-3-6-17(16)27-19;1-3-21(2)13-9-8-12-10-14(19(22)23-16(12)11-13)18-20-15-6-4-5-7-17(15)24-18;3*2-1-3/h4-16H,3H2,1-2H3;2-3,5-8,11-12H,4,9-10H2,1H3,(H,24,25,26);4-11H,3H2,1-2H3;;; |
| InChIKey | JHXKEXQEPHDVBK-UHFFFAOYSA-N |
| XLogP | 11.35 |
| TPSA | 313.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 23 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 92 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1278.34 |
| LogP ≤ 5 | 11.35 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 23 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158921698 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.